New Advice on Artificial Pancreas Insulin Delivery Systems
-
"Automated insulin delivery systems" is becoming the standard terminology — including by the US Food and Drug Administration — to refer to systems that integrate data from a continuous glucose monitoring (CGM) system via a control algorithm into an insulin pump in order to automate subcutaneous insulin delivery. "Hybrid AID" or "hybrid closed-loop" refer to the current status of these systems, which still require some degree of user input to control glucose levels.
-
@haritt The term "artificial pancreas" was used interchangeably with AID in the past, but it doesn't take into account exocrine pancreatic function. The term "bionic pancreas" refers to a specific system in development that would ultimately include glucagon along with insulin. The new consensus report, entitled, "Automated insulin delivery: Benefits, challenges, and recommendations," was published online October 6 in Diabetes Care and Diabetologia.